换一批
换一批Urinary TGF-beta1 reduction related to a decrease of systolic blood pressure in patients with type 2 diabetes and clinical diabetic nephropathy.
第一单位：
Departamento de Medicina Interna da Universidade Federal do Rio Grande do Sul/Hospital de Clínicas de Porto Alegre and Faculdade Federal de Ciências Médicas de Porto Alegre (FFFCMPA)/Hospital Santa Casa de Porto Alegre, Brazil.
作者：
主题词
氨氯地平(Amlodipine);血管紧张素转换酶抑制药(Angiotensin-Converting Enzyme Inhibitors);抗高血压药(Antihypertensive Agents);阿替洛尔(Atenolol);血糖(Blood Glucose);血压(Blood Pressure);卡托普利(Captopril);肌酸酐(Creatinine);糖尿病, 2型(Diabetes Mellitus, Type 2);糖尿病肾病(Diabetic Nephropathies);药物疗法, 联合(Drug Therapy, Combination);依那普利(Enalapril);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);氢氯噻嗪(Hydrochlorothiazide);高血压(Hypertension);男(雄)性(Male);中年人(Middle Aged);钾(Potassium);普萘洛尔(Propranolol);雷米普利(Ramipril);转化生长因子β1(Transforming Growth Factor beta1)
DOI
10.1016/j.diabres.2005.10.027
PMID
16414143
发布时间
2022-12-07
- 浏览7
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
